Login
$AHCO
$7.80 +$0.07 (0.91%) After hours

$AHCO SEC Filings

Filed On Filing
16 Nov 2026 144
13 Nov 2026 144
12 Nov 2026 144
06 Nov 2026 144
05 Nov 2026 144
05 Nov 2026 SCHEDULE 13G/A
03 Nov 2026 10-Q
03 Nov 2026 8-K: Results of Operations and Financial Condition

CONSHOHOCKEN, Pa. – November 3, 2026 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, a...

13 Oct 2026 SCHEDULE 13G/A
08 Oct 2026 SCHEDULE 13G/A
11 Sep 2026 Form 4: Currie Harriss T, CHIEF FINANCIAL OFFICER

Received 141,372 shares as a grant or award

11 Sep 2026 Form 3: Currie Harriss T, CHIEF FINANCIAL OFFICER

Holds 0 shares of Common Stock

08 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of this 7th day of September 2026, by and between AdaptHealth Corp., a Delaware corporation (the “Company”), and Harriss T. Currie (“Executive”).

14 Aug 2026 Form 4/A: Wolf Dale B, Director

Bought 20,000 shares ($126K)

10 Aug 2026 Form 4: Samet Kenneth A, Director

Bought 23,500 shares ($150K)

10 Aug 2026 Form 4: Wolf Dale B, Director

Bought 20,000 shares ($127K) · Bought 20,000 shares ($117K)

04 Aug 2026 10-Q
04 Aug 2026 8-K: Results of Operations and Financial Condition

CONSHOHOCKEN, Pa. – August 4, 2026 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and...

20 Jul 2026 8-K: Entry into a Material Definitive Agreement

CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH “[***]”. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE...

07 Jul 2026 8-K: Regulation FD Disclosure

On July 6, 2026, AdaptHealth LLC (the “Issuer”), an indirect wholly-owned subsidiary of AdaptHealth Corp. (the “Company”), issued a notice of redemption for all of its outstanding 6.125% Senior Notes due 2028 (the “Notes”) in an aggregat...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support